Yazıcı Mutlu U, Ayar Ganime, Savas-Erdeve Senay, Azapağası Ebru, Neşelioğlu Salim, Erel Özcan, Çetinkaya Semra
Dr. Sami Ulus Maternity and Children Training and Research Hospital, University of Health Sciences, Pediatric Intensive Care, Ankara, Turkey.
University of Health Sciences, Ankara Child Health and Diseases, Hematology Oncology Training and Research Hospital, Ankara, Turkey.
Comb Chem High Throughput Screen. 2019;22(8):577-581. doi: 10.2174/1386207322666191008214919.
Ischemia modified albumin (IMA) is a biomarker that has been introduced recently for use in the evaluation of oxidative stress. The aim of this study was to measure the ischemia modified albumin serum levels in pediatric patients with diabetic ketoacidosis (DKA) during acidosis and after the patient recovered from acidosis and to compare these with the control group.
Pediatric patients with Type I diabetes mellitus (T1DM) who were admitted to the pediatric intensive care unit with the diabetic ketoacidosis were assigned as the study group and healthy children who were admitted to the outpatient clinic and decided as healthy after clinic and laboratory evaluation were selected as the control group. IMA and adjusted IMA levels were evaluated in the blood samples from the control group and the study group when admitted first time to the intensive care unit during the acidosis period (DKA before treatment, DKA-BT), and after recovering from acidosis (DKA after treatment, DKA-AT).
A total of 24 pediatric patients with diabetic ketoacidosis and 30 healthy control children matching age and sex were included in the current study. The albumin levels in pediatric patients with T1DM during DKA-BT were higher than the albumin levels after acidosis (4.101±0.373, 3.854±0.369 g/dL, respectively) (p<0.05). However, there was no significant difference when these values were compared to the control group. Mean values of IMA and Adj-IMA were statistically higher in DKAAT compared to the control group (0.748±0.150 vs 0.591±0.099, p< 0.001; 0.708±0.125 vs 0.607±0.824, p< 0.001, respectively). IMA and adjusted IMA levels measured after recovered from acidosis were significantly higher compared to the level of IMA during DKA (0.748±0.150 vs 0.606±0.105 as absorbance unit, p<0.001; 0.708±0.125 vs 0.625±0.100, p<0.05, respectively).
In children with T1DM, even though acidosis recovered following the treatment in diabetic ketoacidosis, which is an oxidative stress marker, the ischemia modified albumin levels and adjusted ischemia modified albumin levels were high.
缺血修饰白蛋白(IMA)是一种最近被引入用于评估氧化应激的生物标志物。本研究的目的是测量糖尿病酮症酸中毒(DKA)患儿在酸中毒期间及酸中毒恢复后的血清缺血修饰白蛋白水平,并与对照组进行比较。
将入住儿科重症监护病房的1型糖尿病(T1DM)并发糖尿病酮症酸中毒的患儿作为研究组,选择门诊就诊且经临床和实验室评估确定为健康的儿童作为对照组。在酸中毒期(治疗前DKA,DKA-BT)首次入住重症监护病房时以及酸中毒恢复后(治疗后DKA,DKA-AT),对对照组和研究组的血样进行IMA和校正IMA水平评估。
本研究共纳入24例糖尿病酮症酸中毒患儿和30例年龄、性别匹配的健康对照儿童。T1DM患儿在DKA-BT期间的白蛋白水平高于酸中毒后(分别为4.101±0.373、3.854±o.369g/dL)(p<0.05)。然而,与对照组比较这些值时无显著差异。与对照组相比,DKA-AT时IMA和校正IMA的平均值在统计学上更高(分别为0. o.748±0.150对0.591±0.099,p<0.001;0.708±0.125对0.607±0.824,p<0.001)。酸中毒恢复后测得的IMA和校正IMA水平显著高于DKA期间的IMA水平(吸光度单位分别为0.748±0.150对0.606±0.105,p<0.001;0.o.708±0.125对0.625±0.100,p<0. o.05)。
在T1DM患儿中,尽管糖尿病酮症酸中毒治疗后酸中毒已恢复,但作为氧化应激标志物的缺血修饰白蛋白水平和校正缺血修饰白蛋白水平仍较高。